Regent Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.1M | Hold |
21,309
| – | – | 0.3% | 93 |
|
|
2022
Q3 | $1.46M | Hold |
21,309
| – | – | 0.42% | 64 |
|
|
2022
Q2 | $964K | Hold |
21,309
| – | – | 0.27% | 91 |
|
|
2022
Q1 | $1.08M | Hold |
21,309
| – | – | 0.25% | 95 |
|
|
2021
Q4 | $1.01M | Hold |
21,309
| – | – | 0.22% | 102 |
|
|
2021
Q3 | $702K | Hold |
21,309
| – | – | 0.17% | 119 |
|
|
2021
Q2 | $1.35M | Hold |
21,309
| – | – | 0.32% | 79 |
|
|
2021
Q1 | $914K | Hold |
21,309
| – | – | 0.23% | 95 |
|
|
2020
Q4 | $1.22M | Hold |
21,309
| – | – | 0.34% | 76 |
|
|
2020
Q3 | $643K | Hold |
21,309
| – | – | 0.2% | 97 |
|
|
2020
Q2 | $696K | Hold |
21,309
| – | – | 0.23% | 91 |
|
|
2020
Q1 | $571K | Hold |
21,309
| – | – | 0.24% | 94 |
|
|
2019
Q4 | $652K | Hold |
21,309
| – | – | 0.2% | 118 |
|
|
2019
Q3 | $513K | Sell |
21,309
-2,000
| -9% | -$48.1K | 0.17% | 129 |
|
|
2019
Q2 | $591K | Buy |
+23,309
| New | +$591K | 0.19% | 123 |
|